Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hodgkin Disease 1

Interventions

Cisplatin 41Radiotherapy 28Radiotherapy, Intensity-Modulated 12Fluorouracil 12Docetaxel 11Paclitaxel 10Cetuximab 10Carboplatin 8Immunohistochemistry 6Platinum 5Radiotherapy, Conformal 4Gene Expression Profiling 4Drug Therapy 4Chemotherapy, Adjuvant 4durvalumab 3Polymerase Chain Reaction 3In Situ Hybridization, Fluorescence 3Afatinib 31,2-diaminocyclohexaneplatinum II citrate 3vandetanib 2Taxes 2Surgical Procedures, Operative 2Reverse Transcriptase Polymerase Chain Reaction 2Radiation 2Panitumumab 2Nimorazole 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2In Situ Hybridization 2Fluorodeoxyglucose F18 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Squamous Cell Carcinoma of Head and Neck × Saline Solution × Clear all
NCT03673735 2021-05-10

ADHERE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡